Earlier testing and tracing could have prevented spread of COVID-19 in U.S. and Europe

Earlier testing and contact tracing might have prevented SARS-CoV-2, the virus that causes COVID-19, from becoming established in the United States and Europe, suggests a new study recently published in Science.

For the study, an international research team-including UBC scientist Dr. Jeffrey Joy-reconstructed the spread of SARS-CoV-2 across the world using genomic data from coronavirus samples, travel records, and computer-simulated models of how the virus spread and mutated over time.

Their analysis reveals an “extended period of missed opportunity” when, they say, intensive testing and contact tracing could have prevented the virus from becoming established in North America and Europe.

In this Q&A, Dr. Joy, an assistant professor in the UBC faculty of medicine’s division of infectious diseases, discusses the findings.

What are the key findings of this study?

Our research revealed that the earliest documented arrivals of SARS-CoV-2 from China into the U.S. (Washington) and Europe (Bavaria, Germany) in early January 2020 did not actually lead to COVID-19 outbreaks, contrary to popular and widespread accounts. In fact, we found that these early cases were very successfully contained by rapid, effective public health interventions, such as testing, contact tracing and effective isolation of suspected cases.

It was actually other, later introductions of the virus from China to both Italy (in late January) and Washington State (in early February) that were responsible for the ignition of the epidemic in both Europe and North America.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below